Prise en charge des hypercholestérolémies de l'enfant

This publication has 26 references indexed in Scilit:

• Novel mutations of thePCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia
  Human Mutation, 2005
• Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
  Atherosclerosis, 2004
• Family History and Cardiovascular Risk in Familial Hypercholesterolemia
  Circulation, 2003
• Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia
  Circulation, 2002
• Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects
  European Journal of Human Genetics, 2000
• Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management
  Atherosclerosis, 1999
• Association of Mutations in the Apolipoprotein B Gene with Hypercholesterolemia and the Risk of Ischemic Heart Disease
  New England Journal of Medicine, 1998
• Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
  The Journal of Pediatrics, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Prevalence and expression of familial combined hyperlipidemia in childhood
  The Journal of Pediatrics, 1990